The increase is more than likely as a BP medication. Just gaining traction in the market over time. This would also apply to Methadone and the others as well.
P D patients would have to wait until Isradipine is approved for P D/ hypertensive patients and can be prescribed as off label is my guess.
But as you have posted, revenues are growing with respect to the generics Elite has out there.